Valuation GSK plc NYSE

Stocks

Market Closed - NYSE 00:00:02 11/09/2026 +04			5-day change	1st Jan Change
48.12 ^USD	-1.05%		-5.41%	-1.88%

09-10	GSK gets Japan approval for prefilled Shingrix vaccine	AN
09-10	GSK Gets Japan Approval for Prefilled Shingrix Syringe	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	71,144	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	-2.81%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	91,866	89,129	86,191
Change	-	-24.65%	-1.89%	-8.24%	28.83%	4.81%	-2.98%	-3.3%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	13.5x	11.2x	10.4x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.34x	3.8x	3.34x
PEG	-	0x	-0.2x	-0.4x	0x	-1.9x	0.5x	1.34x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.1x	2x	1.94x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.71x	2.51x	2.36x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.02x	7.28x	6.79x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	8.92x	8.08x	7.49x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.6x	15.4x	12.7x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.04%	6.5%	7.89%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7495	0.7831
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.92%	4.22%	4.41%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.31	1.591	1.715
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	53.1%	47.1%	45.7%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,949	35,491	36,595
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,453	12,249	12,687
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,298	11,033	11,512
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,380	6,374	6,878
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	20,722	17,985	15,046
Reference price ²	20.08	14.38	14.50	13.46	18.24	17.76	17.76	17.76
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	16.03x	6.35x	15.50x	2.48%	392.19B
Weighted average by Cap.	22.91x	7.53x	17.31x	2.04%